Description
UNIGEF 250 Tablet 10’s unigef 250 tablets 10’s are a vital component in the management of certain types of cancer. Each tablet contains 250mg of Gefitinib, an oral tyrosine kinase inhibitor. This medication is primarily indicated for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) whose tumors have a specific genetic mutation (EGFR). By selectively inhibiting the EGFR tyrosine kinase, UNIGEF helps to slow or stop the growth of cancer cells, potentially improving survival rates and quality of life for patients. The tablets are easy to swallow and should be taken orally once daily, as prescribed by your healthcare provider. Always consult your doctor for dosage and usage instructions to ensure optimal results.
Reviews
There are no reviews yet.